Skip to content
Recall Observatory FDA recall evidence

Drug product

TYVASO (treprostinil) Inhalation Solution Treprostinil 1.74 mg/2.9 mL (0.6 mg/mL) Tyvaso Inhalation System Starter Kit Model# TD-100/A, Rx Only, Manufactured by United Therapeutics Corporation Research Triangle Park, NC 27709, NDC# 6630220601

D-0083-2018

September 11, 2017

Class II

Product summary

Firm
United Therapeutics Corp.
Event
Event 78170
Status
Terminated
Classification
Class II
Quantity
12 devices
Official record key
drug-enforcement:D-0083-2018

Official wording

Reason: CGMP Deviations

Code information: Lot #: 2101152; Exp. 12/11/2017 Lot #: 2101195; Exp. 04/26/2019

Distribution pattern: PA

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations